TM5275 sodium
≥98%
- Product Code: 102962
CAS:
1103926-82-4
| Molecular Weight: | 543.97 g./mol | Molecular Formula: | C₂₈H₂₇ClN₃O₅Na |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
TM5275 sodium is primarily utilized in the field of medicinal chemistry and drug development. It is known for its potential as a therapeutic agent, particularly in the treatment of thrombotic disorders. The compound exhibits anticoagulant properties, making it a candidate for preventing blood clots in conditions such as deep vein thrombosis, pulmonary embolism, and stroke. Its mechanism of action involves the inhibition of specific coagulation factors, thereby reducing the risk of abnormal clot formation. Additionally, TM5275 sodium is being explored for its anti-inflammatory effects, which could be beneficial in managing chronic inflammatory diseases. Research is ongoing to further evaluate its efficacy, safety, and potential applications in various clinical settings.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Beige Powder |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | Ft50,961.53 |
+
-
|
TM5275 sodium
TM5275 sodium is primarily utilized in the field of medicinal chemistry and drug development. It is known for its potential as a therapeutic agent, particularly in the treatment of thrombotic disorders. The compound exhibits anticoagulant properties, making it a candidate for preventing blood clots in conditions such as deep vein thrombosis, pulmonary embolism, and stroke. Its mechanism of action involves the inhibition of specific coagulation factors, thereby reducing the risk of abnormal clot formation. Additionally, TM5275 sodium is being explored for its anti-inflammatory effects, which could be beneficial in managing chronic inflammatory diseases. Research is ongoing to further evaluate its efficacy, safety, and potential applications in various clinical settings.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :